Ibrutinib–Rituximab or Chemoimmunotherapy for Chronic Lymphocytic LeukemiaTait D. Shanafelt, Martin S. Tallman, Susan O’Brien et al.|New England Journal of Medicine|2019Cited by 735
Regulated Expression of BAFF-Binding Receptors during Human B Cell DifferentiationJaime Darce, Diane F. Jelinek|The Journal of Immunology|2007Cited by 261
LEF-1 is a prosurvival factor in chronic lymphocytic leukemia and is expressed in the preleukemic state of monoclonal B-cell lymphocytosisAlbert Gutierrez, Diane F. Jelinek|Blood|2010Cited by 172
Platelet-derived growth factor (PDGF)–PDGF receptor interaction activates bone marrow–derived mesenchymal stromal cells derived from chronic lymphocytic leukemia: implications for an angiogenic switchWei Ding, Neil E. Kay, Traci R. Knox et al.|Blood|2010Cited by 148
Selective Induction of DNA Repair Pathways in Human B Cells Activated by CD4+ T CellsXiaosheng Wu, Diane F. Jelinek|PLoS ONE|2010Cited by 11